A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer.
about
Sequential or alternating administration of docetaxel (Taxotere) combined with FEC in metastatic breast cancer: a randomised phase II trial.Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review.Dose-dense epirubicin and cyclophosphamide followed by docetaxel as adjuvant chemotherapy in node-positive breast cancerAdjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.
P2860
A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
A feasibility study evaluating ...... f node-positive breast cancer.
@en
type
label
A feasibility study evaluating ...... f node-positive breast cancer.
@en
prefLabel
A feasibility study evaluating ...... f node-positive breast cancer.
@en
P2093
P356
P1433
P1476
A feasibility study evaluating ...... of node-positive breast cancer
@en
P2093
D Larsimont
J M Nogaret
M J Piccart
M Paesmans
N O'Higgins
S Bartholomeus
P304
P356
10.1023/A:1008345432342
P577
2000-02-01T00:00:00Z